-
Prescribing Information".
Russian State Register of
Medicines (in Russian). JSC
Biocad.
Retrieved 28
January 2024. "FDA
approves treatment for
adults with Alzheimer's...
-
expired in 2014 in Europe, and in 2019 in the
United States. In
January 2015,
BIOCAD[clarification needed]
announced the
first trastuzumab biosimilar approved...
- * 2GIS * IT *
Alawar *
Biocad *
Geropharm *
Group Unihimtek * CFT
Group *
Diakont *
Danaflex *
Lyudinovocable (Athol) *
Interskol * Median-Filter * World...
-
Dmitry Morozov,
Director General of
Biocad Tatyana Chernovskaya,
Director of the
Department of
Biochemistry of
Biocad Andrei Ulitin,
Acting Researcher at...
-
Kipferon Alfarm combination with IgM, IgA, IgG
Giaferon A/S
Vitafarma Genferon Biocad Opthalamoferon Firn-M with
dimedrol eye
infections Heberon Alfa R BioCubaFarma...
-
combination of Biodesign,
Cambridge Molecular Design,
Polygen and, later,
Biocad and
Biosym Technologies. In late 2003, Pharmacopeia, Inc.
separated its...
- list of
partners by that time
expanded to
several medical schools, and
Biocad company was
among the
sponsors of the program.
Selection in the program...
- observer-blind. Aug 2021–Mar 2023, Singapore,
United States Preclinical BCD-250
Biocad Russia Viral vector Phase I–II (160) Randomized, double-blind, placebo-controlled...
-
using existing mixed microarray data or
using virtual microarray data.
BioCAD is an
information fusion software platform. It
utilizes local and global...
-
amount of
about 54
billion rubles.
Moscow and the
pharmaceutical concern BIOCAD concluded an
offset bargain - the
first in Russia.
Minimum ten
nearest years...
